StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.56−0.64 (-6.96%)

Close on Nov 18, 2026Market cap $764.38MP/E –Yield –

Syndax Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Syndax Pharmaceuticals's market cap was $854.95M on Nov 11, 2026, against $1.72B a year earlier. Over the last 5 years it ranged from $798.22M to $2.04B, with a median of $1.43B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$854.95M-53.2%
2025Dec 31, 2025$1.83B+61.4%
2024Dec 31, 2024$1.13B-24.8%
2023Dec 29, 2023$1.50B-1.6%
2022Dec 30, 2022$1.53B+43.1%
2021Dec 31, 2021$1.07B+23.8%
2020Dec 31, 2020$863.68M+262.4%
2019Dec 31, 2019$238.29M+122.6%
2018Dec 31, 2018$107.03M-45.2%
2017Dec 29, 2017$195.46M+50.0%
2016Dec 30, 2016$130.35M–

More Syndax Pharmaceuticals figures

See a number that looks wrong?